1461096873-e1ac27b3-6a10-4487-9eea-fe5ef1169621

1. A polyfluorene end-capped with at least one charge-transporting moiety.
2. A polyfluorene according to claim 1, wherein the charge-transporting moiety is selected from the group comprising electron-transporting moieties, hole-transporting moieties and ion-transporting moieties.
3. A polyfluorene according to any of claims 1-2, wherein the charge-transporting moiety is selected from the group comprising:
10
wherein R1 and R2 are independently at each occurrence selected from the group comprising straight chain C1-20 alkyl, branched C1-20 alkyl, aryl, substituted aryl, alkylaryl, substituted alkylaryl, alkoxyaryl, substituted alkoxyaryl, aryloxyaryl, substituted aryloxyaryl, dialkylaminoaryl, substituted dialkylaminoaryl, diarylaminoaryl and substituted diarylaminoaryl, and
wherein R3 is independently at each occurrence selected from the group comprising straight chain C1-20 alkyl, branched C1-20 alkyl, aryl, substituted aryl, alkylaryl and substituted alkylaryl.
4. A polyfluorene according to claim 3, wherein R1 and R2 are independently at each occurrence selected from the group comprising 4-methylphenyl, 2-methylphenyl, phenyl, 1-naphthyl, 2-naphthyl, 4-methoxyphenyl, 2-methoxyphenyl, 4-dimethylaminophenyl, 2-dimethylaminophenyl, 4-diphenylaminophenyl and 4-phenoxyphenyl.
5. A polyfluorene end-capped with at least one moiety selected from the group comprising
11
wherein R1 and R2 are independently at each occurrence selected from the group comprising straight chain C1-20 alkyl, branched C1-20 alkyl, aryl, substituted aryl, alkylaryl, substituted alkylaryl, alkoxyaryl, substituted alkoxyaryl, aryloxyaryl, substituted aryloxyaryl, dialkylaminoaryl, substituted dialkylaminoaryl, diarylaminoaryl and substituted diarylaminoaryl, and
wherein R3 is independently at each occurrence selected from the group comprising straight chain C1-20 alkyl, branched C1-20 alkyl, aryl, substituted aryl, alkylaryl and substituted alkylaryl.
6. A polyfluorene according to claim 5, wherein R1 and R2 are independently at each occurrence selected from the group comprising 4-methylphenyl, 2-methylphenyl, phenyl, 1-naphthyl, 2-naphthyl, 4-methoxyphenyl, 2-methoxyphenyl, 4-dimethylaminophenyl, 2-dimethylaminophenyl, 4-diphenylaminophenyl and 4-phenoxyphenyl.
7. A polyfluorene having the formula
12
wherein R4 and R5 are independently at each occurrence selected from the group comprising:
13
R1 and R2 being independently selected from the group comprising straight chain C1-20 alkyl, branched C1-20 alkyl, aryl, substituted aryl, alkylaryl, substituted alkylaryl, alkoxyaryl, substituted alkoxyaryl, aryloxyaryl, substituted aryloxyaryl, dialkylaminoaryl, substituted dialkylaminoaryl, diarylaminoaryl and substituted diarylaminoaryl,
R3 being selected from the group comprising straight chain C1-20 alkyl, branched C1-20 alkyl, aryl, substituted aryl, alkylaryl and substituted alkylaryl,

and wherein R6 and R7 are independently at each occurrence selected from the group comprising straight chain C1-20 alkyl, branched chain C1-20 alkyl, aryl, substituted aryl, alkylaryl, substituted alkylaryl, (CH2)q(OCH2CH2)rOCH3,
q being selected from the range 1q10, r being selected from the range 0r20,

and wherein L and M are independently at each occurrence selected from the group comprising thiophene, substituted thiophene, phenyl, substituted phenyl, phenanthrene, substituted phenanthrene, anthracene, substituted anthracene, any aromatic monomer that can be synthesized as a dibromo-substituted monomer, benzothiadiazole, substituted benzothiadiazole, perylene and substituted perylene,
and wherein mno10, each of m, n, o being independently selected from the range 1-1,000,
and wherein p is selected from the range 0-15,
and wherein s is selected from the range 0-15,
with the proviso that, if R4 is H, R5 is not H, and if R5 is H, R4 is not H.
8. A polyfluorene according to claim 7,
wherein m, p, s, o are 0, and
wherein R4-R7 and R1-R3 are as previously defined.
9. A polyfluorene according to any of the foregoing claims cross-linked to a polyfluorene according to any of the foregoing claims via at least one linkage selected from the group comprising a 9,9-spirobifluorene-linkage, a bifluorenyl-linkage, a bifluorenylidene-linkage and an ,-difluorenylalkane-linkage with a length of the alkane spacer in the range from 1-20 C-atoms.
10. A polyfluorene according to any of the foregoing claims which has at least one color-tuning moiety incorporated into the main chain.
11. A polyfluorene according to claim 10, wherein the color-tuning moiety is selected from the group comprising thiophene, substituted thiophene, phenyl, substituted phenyl, phenanthrene, substituted phenanthrene, anthracene, substituted anthracene, any aromatic monomer that can be synthesized as a dibromo-substituted monomer, benzothiadiazole, substituted benzothiodiazole, perylene and substituted perylene.
12. A polyfluorene according to any of the foregoing claims, which is liquid-crystalline.
13. A polyfluorene according to claim 12, which is liquid-crystalline at or above 70 C.
14. A polyfluorene according to any of claims 1-11, which is amorphous.
15. A polyfluorene selected from the group comprising
14
wherein n is as previously defined.
16. A film incorporating a polyfluorene according to any of the foregoing claims.
17. A film according to claim 16 which is aligned.
18. A film according to any of claims 16-17, incorporating at least one other substance.
19. A film according to claim 18, in which said other substance is selected from the group comprising fluorescent dyes, hole-transporting moieties, electron-transporting moieties, ion-transporting moieties, phosphorescent dyes, nanoparticles, low, molecular weight liquid-crystalline moieties, other liquid-crystalline andor fluorescent andor phosphorescent andor charge-transporting polymers.
20. A film according to any of the claims 16-19, deposited on an alignment layer.
21. A film according to any of the claims 16-20 having a thickness ranging from 10 nm to 2 m.
22. A device selected from the group comprising FETs, photovoltaic elements, LEDs and sensors, incorporating a polyfluorene according to any of claims 1-15.
23. A device according to claim 22 incorporating another polymer.
24. A device according to claim 23 wherein said polymer is a luminescent polymer.
25. A device selected from the group comprising FETs, photovoltaic elements, LEDs and sensors, incorporating a film according to any of claims 16-21.
26. Use of a polyfluorene according to any of claims 1-15 in a film.
27. Use according to claim 24, wherein the film is an emission layer.
28. Use of a polyfluorene according to any of claims 1-15 in a device selected from the group comprising FETs, photovoltaic elements, LEDs and sensors.
29. Use of a film according to any of claims 16-21 in a device selected from the group comprising FETs, photovoltaic elements, LEDs, and sensors.
30. Use of a device according to any of claims 22-25 in combination with a liquid-crystal display (LCD).

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A method comprising:
compression mounting a photovoltaic panel such that at least one rigid or semi-rigid layer of the photovoltaic panel is a constant state of compression in at least a first axis when the photovoltaic panel is mounted for use.
2. The method of claim 1 wherein the layer in the constant state of compression comprises of a glass layer.
3. The method of claim 2 wherein the layer comprises of an un-tempered glass material.
4. The method of claim 2 wherein the layer comprises of a tempered glass material.
5-7. (canceled)
8. The method of claim 1 wherein the panel has a total photovoltaic surface area of at least 1.5 m2.
9. The method of claim 1 wherein the panel has a total photovoltaic surface area of at least 2 m2.
10. The method of claim 1 wherein compression is applied in an amount sufficient for the panel to withstand a load of at least 2400 pa without breakage that an identical panel without the compression mounting could not withstand.
11. The method of claim 1 wherein compression is applied in an amount sufficient for the panel to withstand a load of at least 4000 pa without breakage that an identical panel without the compression mounting could not withstand.
12. The method of claim 1 wherein compression is applied in an amount sufficient for the panel to withstand a load of at least 5400 pa without breakage that an identical panel without the compression mounting could not withstand.
13-14. (canceled)
15. The method of claim 1 wherein the layer being compressioned is a front-side layer of the panel.
16. The method of claim 1 wherein the layer being compressioned is a back-side layer of the panel.
17. The method of claim 1 wherein at least two layers of the panel are in a constant state of compression when the panel is mounted for use.
18. The method of claim 1 wherein compressing the layer compressions the entire panel in one axis.
19. The method of claim 1 further comprising attaching a mounting bracket directly in contact to the layer to be placed in constant compression.
20. The method of claim 19 wherein the mounting bracket is glued to the layer.
21-25. (canceled)
26. The method of claim 1 further comprising using a mounting bracket that is configured to allow the panel to flex in one axis.
27. The method of claim 1 further comprising attaching a plurality of cables to the panel to provide compression.
28. The method of claim 1 further comprising attaching a separate layer of material to extend across an entire underside of the panel and compressing that separate layer compressions the layer in the panel.
29. The method of claim 1 further comprising attaching a net-like layer of material to extend across an entire underside of the panel and compressing that net-like layer compressions the layer in the panel.
30. The method of claim 1 further comprising attaching a separate layer of material between a topside layer of the panel and an bottom layer of the panel, wherein the separate layer extends across the panel in one axis and compressing that separate layer compressions the layer in the panel.
32-47. (canceled)

1461096863-8fea4f39-1e05-4b39-b456-cda6ee62c8b8

1. A content search system comprising:
a content addressable memory (CAM) device having a plurality of rows of CAM cells and a number of counter circuits selectively interconnected by a programmable interconnect structure (PRS) and configured to implement search operations for a regular expression;
a compiler having an input to receive the regular expression and configured to selectively convert the regular expression into a number of first bit groups, a number of second bit groups, and a number of third bit groups; and
an image loader coupled to the compiler and to the CAM device, the image loader configured to load the first bit groups into the CAM cells, to load the second bit groups into a number of memory elements that control configuration of the PRS, and to load the third bit groups into the counter circuits.
2. The search system of claim 1, wherein the first bit groups embody a number of characters of the regular expression, the second bit groups embody a number of metacharacters of the regular expression, and the third bit groups embody a number of quantifiers of the regular expression.
3. The search system of claim 2, wherein a portion of one of the first bit groups configures the PRS to selectively route match results from a first CAM row as an input match signal to any number of other arbitrarily selected CAM rows at the same time.
4. The search system of claim 2, wherein a portion of one of the third bit groups configures the counter circuit to identify only matching portions of an input string that have at least a specified minimum number of characters.
5. The search system of claim 2, wherein a portion of one of the third bit groups configures the counter circuit to identify all matching portions of an input string.
6. The search system of claim 2, wherein a portion of one of the third bit groups configures the counter circuit to count a match length of a matching substring.
7. The search system of claim 2, wherein the metacharacter comprises a logical OR operator.
8. The search system of claim 2, wherein the third bit groups comprise at least one greedy quantifier.
9. The search system of claim 2, wherein one of the quantifiers comprises a Kleene star.
10. The search system of claim 2, wherein one of the quantifiers comprises a \u2018+\u2019 operator.
11. The search system of claim 2, wherein one of the quantifiers comprises a character.
12. The search system of claim 2, wherein one of the quantifiers comprises a \u201c{n,}\u201d interval expression.
13. The search system of claim 2, wherein one of the quantifiers comprises a \u201c{n}\u201d interval expression.
14. The search system of claim 2, wherein one of the quantifiers comprises a \u201c{n,m}\u201d interval expression.
15. The search system of claim 1, further comprising:
a placement module coupled to the compiler and configured to store information indicating which of the counter circuits, CAM rows, and memory elements of the PRS are available for receiving corresponding bit groups.
16. The search system of claim 1, wherein one of the counter circuits includes inputs to receive an active signal, an increment signal, and a reset signal from one or more of the CAM rows, includes a first output to generate a first output signal indicating whether a count value CNT\u2267N, and includes a second output to generate a second output signal whether 0<CNT<N, wherein N is a quantifier specified by the regular expression.
17. The search system of claim 16, wherein the active signal, the increment signal, and the reset signal are generated during a first compare operation in the CAM device, and the first and second output signals selectively enable one or more of the CAM rows for a next compare operation.
18. The search system of claim 1, wherein the compiler transforms regular expression into an architecture-dependent regular expression characterized by a determination of the available resources of the CAM device.
19. A method for programming a content addressable memory (CAM) device having a plurality of rows of CAM cells and a number of counter circuits selectively interconnected by a programmable interconnect structure (PRS) to implement search operations for a regular expression, the method comprising:
compiling the regular expression into a number of first bit groups, a number of second bit groups, and a number of third bit groups;
loading the first bit groups into the CAM cells using an image loader;
loading the second bit groups into a number of memory elements that control configuration of the PRS using the image loader; and loading the third bit groups into the counter circuits using the image loader.
20. The method of claim 19, wherein the first bit groups embody a number of characters of the regular expression, the second bit groups embody a number of metacharacters of the regular expression, and the third bit groups embody a number of quantifiers of the regular expression.
21. The method of claim 20, wherein the metacharacter comprises a logical OR operator.
22. The method of claim 20, wherein a portion of one of the first bit groups configures the PRS to selectively route match results from a first CAM row as an input match signal to any number of other arbitrarily selected CAM rows at the same time.
23. The method of claim 20, wherein a portion of one of the third bit groups configures the counter circuit to identify only matching portions of an input string that have at least a specified minimum number of characters.
24. The method of claim 20, wherein a portion of one of the third bit groups configures the counter circuit to identify all matching portions of an input string.
25. The method of claim 20, wherein a portion of one of the third bit groups configures the counter circuit to count a match length of a matching substring.
26. The method of claim 19, further comprising:
determining which of the counter circuits, CAM rows, and memory elements of the PRS are available for receiving corresponding bit groups.
27. The method of claim 26, further comprising:
selectively altering the compiling in response to the determining.
28. The method of claim 19, wherein compiling the regular expression comprises a reroll operation.
29. The method of claim 19, wherein compiling the regular expression comprises a mid-level alternation split.
30. The method of claim 19, wherein compiling the regular expression comprises a top-level alternation split.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A compound selected from Formula Id:
stereoisomers, geometric isomers, tautomers, and pharmaceutically acceptable salts thereof, wherein:
Z1 is CR1 or N;
Z2 is CR2 or N;
Z3 is CR3 or N;
Z4 is CR4 or N;
R1, R2, R3, and R4 are independently selected from H, F, Cl, Br, I, \u2014CN, \u2014COR10, \u2014CO2R10, \u2014C(\u2550O))N(R10)OR11, \u2014C(\u2550NR10NR10R11, \u2014C(\u2550O)NR10R11, \u2014NO2, \u2014NR10R11, \u2014NR12C(\u2550O)R10, \u2014NR12C(\u2550O)OR11, \u2014NR12C(\u2550O)NR10R11, \u2014NR12C(\u2550)(C1-C12 alkylene)NR10R11, \u2014NR12(C1-C12 alkylene)NR10R11, \u2014NR12(C1-C12 alkylene)OR10, \u2014NR12(C1-C12 alkylene)C(\u2550O)NR10R11, \u2014OR10, \u2014SR10, \u2014S(O)2R10,
\u2014C(\u2550O)NR10(C1-C12 alkylene)NR10R11,
\u2014C(\u2550O)NR10(C1-C12 alkylene)NR10C(\u2550O)OR11,
\u2014C(\u2550O)NR10(C1-C12 alkylene)NR10C(\u2550O)R11,
\u2014C(\u2550O)NR10(C1-C12 alkylene)R10,
C1-C12 alkyl,
C2-C8 alkenyl,
C2-C8 alkynyl,
C3-C12 carbocyclyl,
C2-C20 heterocyclyl,
C6-C20 aryl,
C1-C20 heteroaryl,
\u2014(C3-C12 carbocyclyl)-(C1-C12 alkyl),
\u2014(C2-C20 heterocyclyl)-(C1-C12 alkyl),
\u2014(C6-C20 aryl)-(C1-C12 alkyl),
\u2014(C1-C20 heteroaryl)-(C1-C12 alkyl),
\u2014(C1-C12 alkylene)-(C3-C12 carbocyclyl),
\u2014(C1-C12 alkylene)-(C2-C20 heterocyclyl),
\u2014(C1-C12 alkylene)-(C2-C20 heterocyclyl)-(C2-C20 heterocyclyl),
\u2014(C1-C12 alkylene)-(C2-C20 heterocyclyl)-(C3-C12 carbocyclyl),
\u2014(C1-C12 alkylene)-(C2-C20 heterocyclyl)-C(\u2550O)\u2014(C2-C20 heterocyclyl),
\u2014(C1-C12 alkylene)-(C1-C20 heteroaryl),
\u2014(C1-C12 alkylene)-(C2-C20 heterocyclyl)-(C1-C12 alkyl),
\u2014(C1-C12 alkylene)-(C6-C20 aryl)-(C1-C12 alkyl),
\u2014(C1-C12 alkylene)-(C1-C20 heteroaryl)-(C1-C12 alkyl),
\u2014(C1-C12 alkylene)-C(\u2550O)\u2014(C2-C20 heterocyclyl),
\u2014(C1-C12 alkylene)C(\u2550O)OR10,
\u2014(C1-C12 alkylene)C(\u2550O)NR10R11,
\u2014(C1-C12 alkylene)-NR10R11,
\u2014(C1-C12 alkylene)NR12C(\u2550O)R10,
\u2014(C1-C12 alkylene)OR10,
\u2014(C1-C12 alkylene)-NR10\u2014(C1-C12 alkylene)-(C1-C20 heteroaryl),
\u2014(C1-C12 alkylene)-NR10\u2014(C1-C12 alkylene)-(C1-C20 heterocyclyl),
\u2014(C1-C12 alkylene)-NR10\u2014(C1-C12 alkylene)-NHC(\u2550O)\u2014(C1-C20 heteroaryl),
\u2014(C1-C12 alkylene)-(C2-C20 heterocyclyl)-NR10R11, and
\u2014(C1-C12 alkylene)-(C2-C20 heterocyclyl)-(C1-C12 alkyl)-NR10R11,
where alkyl, alkenyl, alkynyl, alkylene, carbocyclyl, heterocyclyl, aryl, and heteroaryl are optionally substituted with one or more groups independently selected from F, Cl, Br, I, R10, \u2014SR10, \u2014S(O)2R10, \u2014S(O)2NR10R11, \u2014NR10R11, \u2014NR12C(O)R10, \u2014CO2R10, \u2014C(O)R10, \u2014CONR10R11, oxo, and \u2014OR10;
A is selected from \u2014C(\u2550O)NR5R6, \u2014NR5R6, C6-C20 aryl, C2-C20 heterocyclyl and C1-C20 heteroaryl wherein aryl, heterocyclyl and heteroaryl are optionally substituted with one or more groups independently selected from F, Cl, Br, I, \u2014CN, \u2014COR10, \u2014CO2R10, \u2014C(\u2550O)N(R10)OR11, \u2014C(\u2550NR10)NR10R11, \u2014C(\u2550O)NR10R11, \u2014NO2, \u2014NR10R11, \u2014NR12C(\u2550O)R10, \u2014NR12C(\u2550O)OR11, \u2014NR12C(\u2550O)NR10R11, \u2014NR12C(\u2550O)(C1-C12 alkylene)NR10R11, \u2014NR12(C1-C12 alkylene)NR10R11, \u2014NR12(C1-C12 alkylene)OR10, \u2014NR12(C1-C12 alkylene)C(\u2550O)NR10R11, \u2014OR10, \u2014S(O)2R10,
\u2014C(\u2550O)NR10(C1-C12 alkylene)NR10R11,
\u2014C(\u2550O)NR10(C1-C12 alkylene)NR10C(\u2550O)OR11,
\u2014C(\u2550O)NR10(C1-C12 alkylene)NR10C(\u2550O)R11,
\u2014C(\u2550O)NR10(C1-C12 alkylene)R10,
C1-C12 alkyl,
C2-C8 alkenyl,
C2-C8 alkynyl,
C3-C12 carbocyclyl,
C2-C20 heterocyclyl,
C6-C20 aryl,
C1-C20 heteroaryl,
\u2014(C3-C12 carbocyclyl)-(C1-C12 alkyl),
\u2014(C2-C20 heterocyclyl)-(C1-C12 alkyl),
\u2014(C6-C20 aryl)-(C1-C12 alkyl),
\u2014(C1-C20 heteroaryl)-(C1-C12 alkyl),
\u2014(C1-C12 alkylene)-(C3-C12 carbocyclyl),
\u2014(C1-C12 alkylene)-(C2-C20 heterocyclyl),
\u2014(C1-C12 alkylene)-(C2-C20 heterocyclyl)-(C2-C20 heterocyclyl),
\u2014(C1-C12 alkylene)-(C2-C20 heterocyclyl)-(C3-C12 carbocyclyl),
\u2014(C1-C12 alkylene)-(C2-C20 heterocyclyl)-C(\u2550O)\u2014(C2-C20 heterocyclyl),
\u2014(C1-C12 alkylene)-(C1-C20 heteroaryl),
\u2014(C1-C12 alkylene)-(C2-C20 heterocyclyl)-(C1-C12 alkyl),
\u2014(C1-C12 alkylene)-(C6-C20 aryl)-(C1-C12 alkyl),
\u2014(C1-C12 alkylene)-(C1-C20 heteroaryl)-(C1-C12 alkyl),
\u2014(C1-C12 alkylene)-C(\u2550O)\u2014(C2-C20 heterocyclyl),
\u2014(C1-C12 alkylene)C(\u2550O)OR10,
\u2014(C1-C12 alkylene)-NR10R11,
\u2014(C1-C12 alkylene)NR12C(\u2550O)R10,
\u2014(C1-C12 alkylene)OR10,
\u2014(C1-C12 alkylene)-NR10\u2014(C1-C12 alkylene)-(C1-C20 heteroaryl),
\u2014(C1-C12 alkylene)-NR10\u2014(C1-C12 alkylene)-(C1-C20 heterocyclyl),
\u2014(C1-C12 alkylene)-NR10\u2014(C1-C12 alkylene)-NHC(\u2550O)\u2014(C1-C20 heteroaryl),
\u2014(C1-C12 alkylene)-(C2-C20 heterocyclyl)-NR10R11, and
\u2014(C1-C12 alkylene)-(C2-C20 heterocyclyl)-(C1-C12 alkyl)-NR10R11,
where alkyl, alkenyl, alkynyl, alkylene, carbocyclyl, heterocyclyl, aryl, and heteroaryl are optionally substituted with one or more groups independently selected from F, Cl, Br, I, R10, \u2014SR10, \u2014S(O)2R10, \u2014NR10R11, \u2014NR12C(O)R10, \u2014CO2R10, \u2014C(O)R10, \u2014CONR10R11, and \u2014OR10;
R5 is selected from H, and C1-C12 alkyl, optionally substituted with one or more groups independently selected from F, Cl, Br, I, \u2014CN, \u2014CO2H, \u2014CONH2, \u2014CONHCH3, \u2014NH2, \u2014NO2, \u2014N(CH3)2, \u2014NHCOCH3, \u2014NHS(O)2CH3, \u2014OH, \u2014OCH3, \u2014OCH2CH3, \u2014S(O)2NH2, and \u2014S(O)2CH3;
R6 is selected from C1-C12 alkyl, C3-C12 carbocyclyl, C2-C20 heterocyclyl, C1-C20 heteroaryl, and C6-C20 aryl, each optionally substituted with one or more groups independently selected from F, Cl, Br, I, \u2014CH3, \u2014CH2OH, \u2014CH2C6H5, \u2014CN, \u2014CF3, \u2014CO2H, \u2014C(O)CH3, \u2014NH2, \u2014NO2, \u2014N(CH3)2, \u2014NHCOCH3, \u2014NHS(O)2CH3, \u2014OH, oxo, \u2014OCH3, \u2014OCH2CH3, \u2014S(O)2NH2, \u2014S(O)2CH3, \u2014C(\u2550O)NR10(C1-C12 alkylene)NR10R11, phenyl, pyridinyl, tetrahydro-furan-2-yl, 2,3-dihydro-benzofuran-2-yl, 1-isopropyl-pyrrolidin-3-ylmethyl, morpholin-4-yl, piperidin-1-yl, piperazinyl, piperazin-4-yl-2-one, piperazin-4-yl-3-one, pyrrolidin-1-yl, thiomorpholin-4-yl, S-dioxothiomorpholin-4-yl, \u2014C\u2261CR13, \u2014CH\u2550CHR13, and \u2014C(\u2550O)NR10R11;
or R5 and R6 together with the nitrogen atom to which they are attached form C2-C20 heterocyclyl or C1-C20 heteroaryl, optionally substituted with one or more groups selected from F, Cl, Br, I, CH3, C(CH3)3, \u2014CH2OH, \u2014CH2CH2OH, \u2014CH2C6H5, pyridin-2-yl, 6-methyl-pyridin-2-yl, pyridin-4-yl, pyridin-3-yl, pyrimidin-2-yl, pyrazin-2-yl, tetrahydro-furan-carbonyl, 2-methoxy-phenyl, benzoyl, cyclopropylmethyl, (tetrahydrofuran-2-yl)methyl, 2,6-dimethyl-morpholin-4-yl, 4-methyl-piperazine-carbonyl, pyrrolidine-1-carbonyl, cyclopropanecarbonyl, 2,4-difluoro-phenyl, pyridin-2-ylmethyl, morpholin-4-yl, \u2014CN, \u2014CF3, \u2014CO2H, \u2014CONH2, \u2014CONHCH3, \u2014CON(CH3)2, \u2014COCF3, \u2014COCH3, \u2014COCH(CH3)2, \u2014NO2, NHCH3, \u2014N(CH3)2, \u2014N(CH2CH3)2, \u2014NHCOCH3, \u2014NCH3COCH3, \u2014NHS(O)2CH3, \u2014OH, \u2014OCH3, \u2014OCH2CH3, \u2014CH2OCH3, \u2014CH2CH2OCH3, \u2014CH2S(O)2NHCH3, \u2014CH2S(O)2CH2CH3, \u2014S(O)2NHCH3, \u2014S(O)2CH2CH3, \u2014S(O)2NH2, \u2014S(O)2N(CH3)2 and \u2014S(O)2CH3;
R10, R11 and R12 are independently selected from H, C1-C12 alkyl, \u2014(C1-C12 alkylene)-(C2-C20 heterocyclyl), \u2014(C1-C12 alkylene)-(C6-C20 aryl), \u2014(C1-C12 alkylene)-(C3-C12 carbocyclyl), C2-C8 alkenyl, C2-C8 alkynyl, C3-C12 carbocyclyl, C2-C20 heterocyclyl, C6-C20 aryl, and C1-C20 heteroaryl, each of which are optionally substituted with one or more groups independently selected from F, Cl, Br, I, \u2014CH3, \u2014CH2CH3, \u2014CH(CH3)2, \u2014CH2OH, \u2014CH2OCH3, \u2014CH2CH2OH, \u2014C(CH3)2OH, \u2014CH2C(CH3)2OH, \u2014CH2CH(CH3)OH, \u2014CH2CO2H, \u2014CH2CO2CH3, \u2014CH2NH2, \u2014(CH2)2N(CH3)2, \u2014CH2C6H5, \u2014CN, \u2014CF3, \u2014CO2H, \u2014C(O)CH3, \u2014C(O)CH(OH)CH3, \u2014CO2CH3, \u2014CONH2, \u2014CONHCH3, \u2014CON(CH3)2, \u2014C(CH3)2CONH2, \u2014NH2, \u2014NO2, \u2014N(CH3)2, \u2014N(CH3)C(CH3)2CONH2, \u2014N(CH3)CH2CH2S(O)2CH3, \u2014NHCOCH3, \u2014NHS(O)2CH3, \u2550O (oxo), \u2014OH, \u2014OCH3, \u2014OCH2CH3, \u2014OCH2CH2OH, \u2014OP(O)(OH)2, \u2014SCH3, \u2014S(O)2CH3, \u2014S(O)2NH2, \u2014S(O)2N(CH3)2, \u2014CH2S(O)2NHCH3, \u2014CH2S(O)2CH2CH3, \u2014S(O)2NHCH3, \u2014S(O)2CH2CH3, pyrrolidin-1-yl, 2-oxopyrrolidin-1-yl, cyclopropyl, cyclopentyl, oxetanyl, 4-methylpiperazin-1-yl, and 4-morpholinyl;
or R10 and R11 together with the nitrogen atom to which they are attached form a C2-C20 heterocyclyl ring or C1-C20 heteroaryl each of which are optionally substituted with one or more groups independently selected from F, Cl, Br, I, \u2014CH3, \u2014CH2OH, \u2014CH2C6H5, \u2014CN, \u2014CF3, \u2014CO2H, \u2014CONH2, \u2014CONHCH3, \u2014NO2, \u2014N(CH3)2, \u2014NHCOCH3, \u2014NHS(O)2CH3, \u2014OH, oxo, \u2014OCH3, \u2014OCH2CH3, \u2014S(O)2NH2, \u2014S(O)2CH3, \u2014CH(CH3)2, \u2014CH2CF3, \u2014CH2CH2OH and \u2014C(CH3)2OH; and
R13 is selected from H, F, Cl, Br, I, \u2014CH3, \u2014CH2CH3, \u2014CN, \u2014CF3, \u2014CH2N(CH3)2, \u2014CH2OH, \u2014CO2H, \u2014CONH2, \u2014CON(CH3)2, \u2014NO2, and \u2014S(O)2CH3.
2. The compound of claim 1 wherein
Z1 is CR1;
Z2 is CR2;
Z3 is CR3; and
Z4 is CR4.
3. The compound of claim 1 wherein
Z1 is N;
Z2 is CR2;
Z3 is CR3; and
Z4 is CR4.
4. The compound of claim 1 wherein
Z1 is CR1;
Z2 is N;
Z3 is CR3; and
Z4 is CR4.
5. The compound of claim 1 wherein
Z1 is CR1;
Z2 is CR2;
Z3 is N; and
Z4 is CR4.
6. The compound of claim 1 wherein
Z1 is CR1;
Z2 is CR2;
Z3 is CR3; and
Z4 is N.
7. The compound of claim 1 wherein R1, R2, R3 and R4 are independently selected from H, F, Cl, Br, I, CN, NO2, and C1-C6 alkyl.
8. The compound of claim 1 wherein R2 and R3 are independently selected from \u2014NR10R11, \u2014(C(\u2550O)NR10R11 and \u2014(C1-C12 alkylene)C(\u2550O)NR10R11.
9. The compound of claim 1 wherein R2 and R3 are independently selected from optionally substituted C3-C12 carbocyclyl, C2-C20 heterocyclyl, C6-C20 aryl, and C1-C20 heteroaryl.
10. The compound of claim 9 wherein R2 and R3 are independently selected from optionally substituted azabicyclo3.2.1octanyl, azetidinyl, cyclopropyl, 3,8-diazabicyclo3.2.1octanyl, dihydropyrrolidinyl, imidazolyl, morpholinyl, oxetanyl, phenyl, piperazinone, piperazinyl, piperidyl, pyrazinyl, pyrazolyl, pyridinyl, pyridinone, pyrimidinyl, pyrrolidinyl, tetrahydropyranyl, and tetrahydropyridinyl.
11. The compound of claim 1 wherein R2 and R3 are independently \u2014OR10.
12. The compound of claim 11 wherein R2 is \u2014OR10 and Z3 is N.
13. The compound of claim 1 wherein A is \u2014C(\u2550O)NR5R6.
14. The compound of claim 13 wherein R5 is CH3.
15. The compound of claim 13 wherein R6 is phenyl substituted with one or more groups independently selected from F, Cl, Br, I, \u2014CH2OH, \u2014CH2C6H5, \u2014CN, \u2014CF3, \u2014CO2H, \u2014CONH2, \u2014CONHCH3, \u2014NO2, \u2014N(CH3)2, \u2014NHCOCH3, \u2014NHS(O)2CH3, \u2014OH, \u2014OCH3, \u2014OCH2CH3, \u2014S(O)2NH2, \u2014S(O)2CH3, morpholin-4-yl, piperidin-1-yl, piperazinyl, piperazin-4-yl-2-one, piperazin-4-yl-3-one, pyrrolidin-1-yl, thiomorpholin-4-yl, S-dioxothiomorpholin-4-yl, \u2014C\u2261CR13, and \u2014CH\u2550CHR13.
16. The compound of claim 1 wherein R5 and R6 together with the nitrogen atom to which they are attached form morpholin-4-yl, piperidin-1-yl, piperazinyl, piperazin-4-yl-2-one, piperazin-4-yl-3-one, pyrrolidin-1-yl, thiomorpholin-4-yl, S-dioxothiomorpholin-4-yl, azocan-1-yl, azetidin-1-yl, octahydropyrido1,2-apyrazin-2-yl, 1,4diazepan-1-yl, or indolinyl.
17. The compound of claim 1 wherein A is C2-C20 heterocyclyl or C1-C20 heteroaryl substituted with \u2014CH2OH, \u2014CH2CO2H, \u2014CH(CH3)CH2OCH3, \u2014CH3, \u2014CH(CH3)2, \u2014CH2CH(CH3)2, \u2014CH2CF3, \u2014C(\u2550O)CH3, \u2014C(\u2550O)NHCH3, \u2014C(\u2550O)N(CH3)2, \u2014CO2H, \u2014CO2CH3, \u2014CH2CO2CH3, \u2014NH2, \u2014NHC(\u2550O)CH3, \u2014OH, \u2014OCH3, \u2014S(O)2CH3, 1-methylpiperid-4-yl, 4-methylpiperazin-1-yl, 4-morpholinyl, (4-methylpiperazin-1-yl)carboxamide, \u2014CH2(1H-1,2,4-triazol-5-yl), cyclopropyl, cyclopropylmethyl, or cyclobutyl.
18. The compound of claim 17 wherein A is a C1-C20 heteroaryl selected from pyridyl, isoxazolyl, imidazolyl, pyrazolyl, pyrrolyl, thiazolyl, pyridazinyl, pyrimidinyl, pyrazinyl, oxazolyl, oxadiazolyl, 1,3,4-oxadiazol-2(3H)-one, furanyl, thienyl, 1,2,3-triazolyl, 1,2,4-triazolyl, 1,2,4-triazol-5(4H)-one, 4,5-dihydro-1,2,4-triazin-6(1H)-one, tetrazolyl, pyrrolo2,3-bpyridinyl, indazolyl, 3,4-dihydroquinolinyl, and benzodthiazole.
19. The compound of claim 1 wherein A is selected from the structures:
where R9 is independently selected from H, F, Cl, Br, I, \u2014CH3, \u2014CH2CH3, \u2014CH(CH3)2, \u2014C(CH3)3, \u2014CH2CH(CH3)2, \u2014CH2OH, \u2014CH2CO2H, \u2014CH(CH3)CH2OCH3, \u2014CN, \u2014CF3, \u2014CH2CF3, \u2014CH2NH2, \u2014CH2CH2NH2, \u2014C(\u2550O)CH3, \u2014CH2C(\u2550O)NHCH3, \u2014C(\u2550O)NHCH3, \u2014CO2H, \u2014CH2CO2CH3, \u2014NH2, \u2014OH, \u2014OCH3, \u2014SCH3, \u2014S(O)2CH3, cyclopropyl, cyclopropylmethyl, 1-methylpiperid-4-yl, 4-methylpiperazin-1-yl, 4-morpholinyl, morpholin-4-yl-ethyl, benzyl, and phenyl, where benzyl and phenyl are optionally substituted with one or more groups selected from F, Cl, Br, I, \u2014CH2OH, \u2014CH2CO2H, \u2014CN, \u2014CH2NH2, \u2014CH3, \u2014C(\u2550O)CH3, \u2014C(\u2550O)NHCH3, \u2014CO2H, \u2014CH2CO2CH3, \u2014NH2, \u2014OCH3, \u2014S(O)2CH3, 1-methylpiperid-4-yl, 4-methylpiperazin-1-yl, and 4-morpholinyl; and where the wavy line indicates the site of attachment.
20. The compound of claim 19 wherein R9 is \u2014CH(CH3)2.
21. The compound of claim 19 wherein A is substituted 1H-1,2,4-triazol-5-yl.
22. The compound of claim 19 wherein A is selected from the structures:
where the wavy line indicates the site of attachment.
23. A compound of claim 1 selected from:
2-(1-(2-chlorophenyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-10-carboxamide; 2-(1-(2-chlorophenyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxamide;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-10-carboxamide;
(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-10-yl)(S-dioxothiomorpholino)methanone;
(4-(2-hydroxypropan-2-yl)piperidin-1-yl)(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-10-yl)methanone;
2-(1-isopropyl-1H-pyrazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-10-carboxamide;
N-(2-(methylsulfonyl)ethyl)-2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-10-carboxamide;
(4-isopropylpiperazin-1-yl)(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-10-yl)methanone;
N-(1-hydroxy-2-methylpropan-2-yl)-2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-10-carboxamide;
(4-(2-hydroxyethyl)piperazin-1-yl)(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-10-yl)methanone;
morpholino(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-10-yl)methanone;
(4-hydroxypiperidin-1-yl)(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-10-yl)methanone;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-N-(2-(methylsulfonyl)ethyl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxamide;
2-(1-(2-chlorophenyl)-1H-1,2,4-triazol-5-yl)-N-(2-(methylsulfonyl)ethyl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxamide;
2-(1-(2-chlorophenyl)-1H-1,2,4-triazol-5-yl)-N-(1-hydroxy-2-methylpropan-2-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-10-carboxamide;
(2-(1-(2-chlorophenyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-10-yl)(4-isopropylpiperazin-1-yl)methanone;
2-(1-(2,4-difluorophenyl)-1H-1,2,4-triazol-5-yl)-N-(1-hydroxy-2-methylpropan-2-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-10-carboxamide;
2-(4-cyano-1-isopropyl-1H-pyrazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxamide;
2-(1-(2-chlorophenyl)-1H-1,2,4-triazol-5-yl)-N-methyl-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxamide;
((3S,5R)-3,5-dimethylpiperazin-1-yl)(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-10-yl)methanone;
N-methyl-2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxamide;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-N-methyl-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxamide;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-10-(1H-pyrazol-4-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(1-(2-chlorophenyl)-1H-imidazol-2-yl)-N-(1-hydroxy-2-methylpropan-2-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-10-carboxamide;
(2-(1-(2,4-difluorophenyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-10-yl)(4-(2-hydroxyethyl)piperazin-1-yl)methanone;
N-(1-hydroxy-2-methylpropan-2-yl)-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxamide;
N-(1-hydroxy-2-methylpropan-2-yl)-2-(1-(S-dioxo-tetrahydrothiophen-3-yl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-10-carboxamide;
2-(1-(2-chlorophenyl)-1H-1,2,4-triazol-5-yl)-N-(1-hydroxy-2-methylpropan-2-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxamide;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-N-methoxy-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxamide;
N-hydroxy-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxamide;
2-(1-(2,4-difluorophenyl)-1H-1,2,4-triazol-5-yl)-N-methyl-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxamide;
1-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropan-2-ol;
2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)ethanol;
methyl 2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxylate;
methyl 2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxylate;
2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)ethanol;
10-bromo-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
1-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropan-2-ol;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-(1-(2-(methylsulfonyl)ethyl)azetidin-3-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(3-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)azetidin-1-yl)acetamide;
(1-aminocyclopropyl)(3-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)azetidin-1-yl)methanone;
9-bromo-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
1-(4-(2-(1-isopropyl-4-methyl-1H-imidazol-2-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropan-2-ol;
2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide;
2-(3-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)azetidin-1-yl)-N,N-dimethylethanesulfonamide;
2-(3-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)azetidin-1-yl)-N,N-dimethylacetamide;
9-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
N-isopropyl-2-(3-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)azetidin-1-yl)acetamide;
2-(3-{2-2-(2,4-Difluoro-phenyl)-2H-1,2,4triazol-3-yl-4,5-dihydro-2H-6-oxa-1,2-diaza-benzoeazulen-8-yl}-azetidin-1-yl)-ethanol;
1-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-imidazol-1-yl)-2-methylpropan-2-ol;
3-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-10-yl)pyridin-2(1H)-one;
9-(1-(2-(3-fluoroazetidin-1-yl)ethylsulfonyl)azetidin-3-yl)-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(3-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)azetidin-1-yl)-2-methylpropanamide;
2-(4-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)ethanol;
2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-imidazol-1-yl)ethanol;
2-(5-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-imidazol-1-yl)ethanol;
2-(1-(2-morpholinoethyl)-1H-imidazol-2-yl)-10-(1H-pyrazol-4-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-9-(1-(2-morpholinoethyl)-1H-pyrazol-4-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(4-(2-(3-amino-1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)ethanol;
2-(3-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)azetidin-1-yl)-N-methylacetamide;
1-(4-(2-(3-amino-1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropan-2-ol;
1-(4-(2-(1-isopropyl-1H-imidazol-2-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropan-2-ol;
2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide;
2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoic acid;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-(1H-pyrazol-4-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
3-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-10-yl)pyridin-2(1H)-one;
5-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)pyridin-2-amine;
2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-imidazol-1-yl)ethanol;
2-(2-(9-(1-(2-hydroxy-2-methylpropyl)-1H-pyrazol-4-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1H-imidazol-1-yl)-N-methylacetamide;
N,N-diethyl-2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)ethanamine;
5-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)pyrimidin-2-amine;
9-(1H-imidazol-5-yl)-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-(1-(2-(methylsulfonyl)ethyl)piperidin-4-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)acetamide;
2-hydroxy-1-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-2-methylpropan-1-one;
(2S)-2-hydroxy-1-(3-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)azetidin-1-yl)propan-1-one;
2-(4-(2-(3-amino-1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-imidazol-1-yl)ethanol;
2-(3-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)azetidin-1-yl)ethanol;
5-(5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1-isopropyl-1H-1,2,4-triazol-3-amine;
2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido4,3-f1,4oxazepine;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-10-(4-methylpiperazin-1-yl)-5,6-dihydroimidazo1,2-dpyrido4,3-f1,4oxazepine;
2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-9-(pyrimidin-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
9-(5-fluoropyridin-3-yl)-2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(3-amino-1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carbonitrile;
N-(5-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)pyridin-2-yl)acetamide;
9-bromo-2-(1-isopropyl-3-(methylthio)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
5-(9-(5-fluoropyridin-3-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1-isopropyl-1H-1,2,4-triazol-3-amine;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-(1-(tetrahydro-2H-pyran-2-yl)-1H-imidazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
3-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide;
2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-9-(pyridin-3-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
5-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-N,N-dimethylpyrimidin-2-amine;
5-(5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1-isopropyl-N-methyl-1H-1,2,4-triazol-3-amine;
N-isopropyl-2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)acetamide;
2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-N,2-dimethylpropanamide;
2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-N,N-dimethylethanesulfonamide;
2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)acetamide;
2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoic acid;
1-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-imidazol-1-yl)-2-methylpropan-2-ol;
5-(9-fluoro-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1-isopropyl-1H-1,2,4-triazol-3-amine;
2-(4-(2-(3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)ethanol;
2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-2-methyl-1H-imidazol-1-yl)ethanol;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-(2-methyl-1-(2-(tetrahydro-2H-pyran-2-yloxy)ethyl)-1H-imidazol-4-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
5-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)pyrimidin-2-amine;
5-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-10-yl)pyridin-2(1H)-one;
5-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-10-yl)pyridin-2(1H)-one;
1-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-2-methyl-1H-imidazol-1-yl)-2-methylpropan-2-ol;
N-(azetidin-3-yl)-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido4,3-f1,4oxazepin-10-amine;
3-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido4,3-f1,4oxazepin-10-ylamino)propane-1,2-diol;
3-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-10-yl)pyridine-2(1H)-one;
9-chloro-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepine;
1-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-2-methyl-1H-imidazol-1-yl)-2-methylpropan-2-ol;
N-(azetidin-3-yl)-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido4,3-f1,4oxazepin-10-amine;
3-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido4,3-f1,4oxazepin-10-ylamino)propane-1,2-diol;
3-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-10-yl)pyridin-2(1H)-one;
3-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido4,3-f1,4oxazepin-10-yl)pyridin-2(1H)-one;
2-(5-(9-cyclopropyl-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-3-methyl-1H-1,2,4-triazol-1-yl)propan-1-ol;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-(2-methyl-1H-imidazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
1-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1-methyl-1H-imidazol-2-yl)-2-methylpropan-2-ol;
1-(4-(2-(3-(hydroxymethyl)-1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropan-2-ol;
N-tert-butyl-2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)acetamide;
2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-N-methylacetamide;
N-ethyl-2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)acetamide;
N-isopropyl-2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)acetamide;
2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-N,N-dimethylacetamide;
2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-N-methylacetamide;
10-fluoro-2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
9-(1,2-dimethyl-1H-imidazol-4-yl)-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
5-(10-fluoro-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1-isopropyl-1H-1,2,4-triazol-3-amine;
9,10-difluoro-2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(4-(2-(1,3-dimethyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)ethanol;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-(1-(2-methoxyethyl)piperidin-4-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-2-methylpropanamide;
2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)ethanol;
2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-2-methylpropanamide;
1-(5-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-imidazol-2-yl)-2-methylpropan-2-ol;
9-(1,2-dimethyl-1H-imidazol-5-yl)-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
1-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-2-methylpropan-2-ol;
2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)ethanol; and
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-(tetrahydro-2H-pyran-4-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine.
24. A compound of claim 1 selected from:
methyl 2-(2-ethoxyphenyl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxylate;
methyl 2-(3-isopropylphenyl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxylate;
methyl 2-(2-ethylphenyl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxylate;
methyl 2-(2-isopropylphenyl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxylate;
methyl 2-(3-(trifluoromethyl)phenyl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxylate;
2-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)acetamide;
2-(5-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-2-methyl-1H-imidazol-1-yl)ethanol;
1-(4-(2-(1-isopropyl-3-(methoxymethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropan-2-ol;
(3R,4R)-4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-3-ol;
racemic-cistrans-2-(3-hydroxy-4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-N,N-dimethylacetamide;
2-(5-(9-bromo-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1-isopropyl-1H-1,2,4-triazol-3-yl)acetamide;
5-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido4,3-f1,4oxazepin-10-yl)pyridin-2(1H)-one;
4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido4,3-f1,4oxazepin-10-yl)piperazin-2-one;
2-(4-(2-(1-isopropyl-3-(methoxymethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)acetamide;
2-(1-isopropyl-3-(methoxymethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-methoxy-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepine;
9-fluoro-2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
5-(9,10-difluoro-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1-isopropyl-1H-1,2,4-triazol-3-amine;
9-bromo-2-(3-cyclopropyl-1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
9-(1-ethylpiperidin-4-yl)-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
(5-(5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1-isopropyl-1H-1,2,4-triazol-3-yl)methanol;
3-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)propanamide;
9-chloro-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepine;
1-(5-(5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1-isopropyl-1H-1,2,4-triazol-3-yl)-N,N-dimethylmethanamine;
racemic-cis-2-(3-hydroxy-4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-N,N-dimethylacetamide;
racemic-trans-2-(3-hydroxy-4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-N,N-dimethylacetamide;
2-((1R,3r,5S)-3-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-8-azabicyclo3.2.1octan-8-yl)acetamide
2-((1R,3 s,5S)-3-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-8-azabicyclo3.2.1octan-8-yl)acetamide;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-(4-methylpiperazin-1-yl)-5,6-dihydroimidazo1,2-dpyrido3,2-f1,4oxazepine;
4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,2-f1,4oxazepin-9-yl)piperazin-2-one;
4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)piperazin-2-one;
4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-10-yl)pyridin-2(1H)-one;
(3R,4S)-4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-3-ol;
2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-N,N-dimethylacetamide;
2-(3-hydroxy-4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-N,2-dimethylpropanamide;
2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)piperazin-1-yl)-N,N-dimethylacetamide;
2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)piperazin-1-yl)acetamide;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,2-f1,4oxazepin-9(8H)-one;
2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,2-f1,4oxazepin-9-yl)piperazin-1-yl)-N-methylacetamide;
2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,2-f1,4oxazepin-9-yl)piperazin-1-yl)-N,N-dimethylacetamide;
2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)acetic acid;
1-((2-(1-isopropyl-1H-pyrazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)methyl)urea;
(2S)-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)piperidine-4-carboxamide;
1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)piperidin-4-ol;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-morpholino-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepine;
N-isopropyl-2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)piperazin-1-yl)acetamide;
1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,2-f1,4oxazepin-9-yl)azetidine-3-carboxamide;
(2S)-2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)propanamide;
(2R)-2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)propanamide;
2-(1-isopropyl-1H-pyrazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carboxamide;
(2-(1-isopropyl-1H-pyrazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)methanamine;
2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-9-(oxetan-3-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(3-hydroxy-4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-N,2-dimethylpropanamide;
2-(3-hydroxy-4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-N,2-dimethylpropanamide;
2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)acetamide;
N-hydroxy-2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)acetamide;
(9-(1-(2-hydroxy-2-methylpropyl)-1H-pyrazol-4-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)(S-dioxothiomorpholino)methanone;
1-((2-(1-(2,4-difluorophenyl)-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)methyl)urea;
(2-(1-(2,4-difluorophenyl)-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)methanamine;
9-(1-(2-(dimethylamino)-2-oxoethyl)piperidin-4-yl)-N-(2-hydroxyethyl)-N-isopropyl-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-2-carboxamide;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-(1-isopropylpiperidin-4-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-2-methylpropan-1-ol;
2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-2-methylpropan-1-ol;
4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)pyrazolidine-3,5-dione;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(3-hydroxy-4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidin-1-yl)-N,N-dimethylacetamide;
1-((2-(1-(2,4-difluorophenyl)-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)methylamino)-2-methylpropan-2-ol;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepine;
(2R)-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-(pyrrolidin-1-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepine;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-N-methyl-5,6-dihydroimidazo1,2-dpyrido3,2-f1,4oxazepin-9-amine;
(2S,4R)-4-hydroxy-1-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S)-1-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)azetidin-3-ol;
(3R)-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidin-3-ol;
(1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)piperidin-4-yl)methanol;
(2S,4S)-4-fluoro-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S,4R)-4-hydroxy-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S)-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2R)-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S)-1-(2-(1-isopropyl-1H-imidazol-2-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S)-1-(2-(1-(2,4-difluorophenyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2R)-2-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)pyrrolidine-1-carboxamide;
(2S)-2-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)pyrrolidine-1-carboxamide;
(2S)-4,4-difluoro-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S,4S)-4-fluoro-1-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S)-4,4-difluoro-1-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S,4S)-4-hydroxy-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S,4S)-4-hydroxy-1-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
2-(1-isopropyl-1H-imidazol-2-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepine;
(5-(9-chloro-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-2-yl)-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-3-yl)methanol;
(2R)-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)-2,5-dihydro-1H-pyrrole-2-carboxamide;
(2S)-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)-2,5-dihydro-1H-pyrrole-2-carboxamide;
(5-(9-(pyrrolidin-1-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-2-yl)-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-3-yl)methanol;
(2S)-1-(2-(1-(3,5-difluorophenyl)-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S)-2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-ylamino)propanamide;
(2S)-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)-3,3-dimethylpyrrolidine-2-carboxamide;
(5-(9-(dimethylamino)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-2-yl)-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-3-yl)methanol;
(2S,3S)-3-hydroxy-1-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S,3R)-3-hydroxy-1-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S,3R)-3-hydroxy-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S,3S)-3-hydroxy-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S)-1-(2-(3-methyl-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S,4R)-4-fluoro-1-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S,4R)-4-fluoro-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S)-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)-2-methylpyrrolidine-2-carboxamide;
1-isopropyl-4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidine-3-carboxamide;
2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-ylamino)acetamide;
(2S)-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)-N-methylpyrrolidine-2-carboxamide;
(2S,3S)-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)-3-methylpyrrolidine-2-carboxamide;
(2S,4R)-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)-4-methoxypyrrolidine-2-carboxamide;
(2S,3S)-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)-3-methoxypyrrolidine-2-carboxamide;
(2S)-1-(2-(1-cyclohexyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S)-1-(2-(1-(2-chlorophenyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
9-bromo-2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
ethyl 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoate;
(5-(9-(dimethylamino)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-2-yl)-1-isopropyl-1H-1,2,4-triazol-3-yl)methanol;
4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1-methyl-1,2,5,6-tetrahydropyridine-3-carboxamide;
4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1-methyl-1,2,3,6-tetrahydropyridine-3-carboxamide;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-N-methyl-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-amine;
(5-(9-(3,3-difluoroazetidin-1-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-2-yl)-1-isopropyl-1H-1,2,4-triazol-3-yl)methanol;
9-chloro-2-(1-isopropyl-1H-pyrazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepine;
2-(3-methyl-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-9-2-(1-methylpiperidin-2-yl)pyrrolidin-1-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepine;
2-(3-methyl-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-9-(2-(2-methylbenzyl)pyrrolidin-1-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepine;
2-(3-methyl-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-9-(2-(piperidin-1-ylmethyl)pyrrolidin-1-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepine;
2-(1-(2-chlorophenyl)-1H-1,2,4-triazol-5-yl)-N,N-dimethyl-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-amine;
2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-9-(1-methyl-1H-pyrazol-4-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(3-amino-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-10-carbonitrile;
2-(3-amino-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carbonitrile;
(2S)-2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yloxy)propanamide;
2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yloxy)acetamide;
2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)acetamide;
2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yloxy)-2-methylpropanamide;
(2S,4R)-4-cyano-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
5-(9-cyclopropyl-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1-isopropyl-1H-1,2,4-triazol-3-amine;
5-(10-fluoro-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-3-amine;
(2S)-1-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S)-1-(2-(1-isopropyl-1H-pyrazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
3-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-2-methylpropanamide;
(2S)-2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)propanamide;
(3S)-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)pyrrolidine-3-carbonitrile;
N-((1H-pyrazol-5-yl)methyl)-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-amine;
2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-ylamino)propan-1-ol;
2-(1-isopropyl-3-(methoxymethyl)-1H-1,2,4-triazol-5-yl)-9-methyl-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
N-(3,4-dimethoxybenzyl)-2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-amine;
5-(10-cyclopropyl-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-3-amine;
2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-9-carbonitrile;
2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-ylamino)acetamide;
2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)ethanesulfonamide;
2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yloxy)propanamide;
9-(difluoromethyl)-2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1-methyl-1,2,3,6-tetrahydropyridine-3-carboxamide;
4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1-methyl-1,2,3,6-tetrahydropyridine-3-carboxamide;
2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-ylamino)-1-(1-methyl-1H-imidazol-2-yl)ethanol;
2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-amine;
2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yloxy)-3-methylbutanamide;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-amine;
2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-10-(1-methyl-1H-pyrazol-4-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine-10-carbonitrile;
2-(1-(2,4-difluorophenyl)-1H-1,2,4-triazol-5-yl)-N-(2-(methylsulfonyl)benzyl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-amine;
1-(2-(2-(1-(2,4-difluorophenyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-ylamino)ethyl)pyrrolidin-2-one;
2-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-ylamino)acetamide;
1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidine-2-carboxamide;
2-((2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)(methyl)amino)acetamide;
N-(3-(1H-imidazol-1-yl)propyl)-2-(1-(2,4-difluorophenyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-amine;
N-((1H-imidazol-2-yl)methyl)-2-(1-(2,4-difluorophenyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-amine;
2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-amine;
1-(2,2,2-trifluoroethyl)-5-(10-(trifluoromethyl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1H-1,2,4-triazol-3-amine;
2-(2-(1-(2,4-difluorophenyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-ylamino)-1-(1-methyl-1H-imidazol-2-yl)ethanol;
8-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-yl)-3,8-diazabicyclo3.2.1octan-2-one;
3-methyl-2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)butanamide;
2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-ol;
(2S)-1-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
(2S)-1-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidine-2-carboxamide;
(3S)-4-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)morpholine-3-carboxamide;
2-methyl-2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)propanamide;
(2R)-2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-ylamino)propanamide;
2-(2-(3-methyl-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-ylamino)acetamide;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-(2-(methylsulfonyl)phenyl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)benzamide;
9-(2-ethylphenyl)-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
(2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)phenyl)methanol;
2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-amine;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-amine;
2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-10-methyl-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-9-methyl-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
10-(difluoromethyl)-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido4,3-f1,4oxazepine;
1-isopropyl-5-(10-(trifluoromethyl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1H-1,2,4-triazol-3-amine;
(2R)-2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)propanamide;
(2S)-2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)propanamide;
(2R)-2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)propanamide;
N-(3,4-dimethoxybenzyl)-2-(3-methyl-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-amine;
2-(3-methyl-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-amine;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-ol;
2-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-ylamino)acetic acid;
9-(difluoromethoxy)-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-amine;
(2S)-2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)butanamide;
(2R)-2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)butanamide;
2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo1,2-dpyrido3,4-f1,4oxazepin-9-ylamino)acetamide;
3-((2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)methyl)oxetan-3-amine;
1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidine-2-carboxamide;
9-ethyl-2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperidine-2-carboxamide;
(2S)-3-methyl-2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)butanamide;
(2R)-3-methyl-2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)butanamide;
ethyl 3-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoate;
methyl 3-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoate;
2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-9-(1H-pyrazol-4-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
3-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoic acid;
9-isopropoxy-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
methyl 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoate;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-(oxetan-3-yloxy)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
9-ethoxy-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-(2,2,2-trifluoroethoxy)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
(2S)-2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)propanoic acid;
(2S)-3-hydroxy-2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)propanamide;
(2S)-2-(2-(1-isopropyl-1H-11580493,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)butanamide;
2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-9-methoxy-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-9-methoxy-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
9-ethoxy-2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
9-isopropoxy-2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-9-(2,2,2-trifluoroethoxy)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-9-(oxetan-3-yloxy)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
9-cyclopropoxy-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
9-cyclobutoxy-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
9-cyclobutoxy-2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
N-((3-aminooxetan-3-yl)methyl)-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-amine;
(3-amino-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)azetidin-3-yl)methanol;
2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-ylamino)acetamide;
1-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)cyclopropanecarboxamide;
2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)cyclopropanecarboxamide;
(2S)-2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-ylamino)propanamide;
2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)cyclopropanecarboxamide;
(2S)-3-hydroxy-2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)propanamide;
2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)pentanamide; and
2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)-4-methylpentanamide.
25. A compound of claim 1 selected from:
9-cyclopropoxy-2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)-3-methylbutanamide;
2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-ylthio)propanamide;
2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-ylthio)propanamide;
(2S)-1-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)azetidine-2-carboxamide;
(2S)-2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-ylamino)propanamide;
(2S)-2-(2-(1-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)propanamide;
(2S)-4-hydroxy-2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)butanamide;
(2S)-3-methoxy-2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-ylamino)propanamide;
(2S)-1-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)piperazine-2-carboxamide;
(2S)-2-(2-(1-ethyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)propanamide;
(2S)-2-(2-(1-tert-butyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)propanamide;
(2S)-2-(2-(1-(2,4-difluorophenyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)propanamide;
(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)methyl carbamate;
(2S)-1-(2-(3-methyl-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)pyrrolidine-2-carboxamide;
2-cyclopropyl-2-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)acetamide;
(2S)-2-((2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)(methyl)amino)propanamide;
(2S)-1-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)azetidine-2-carboxamide;
1-((2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)methyl)-1-methylurea;
(2S)-1-(2-(3-methyl-1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)azetidine-2-carboxamide;
(2S)-2-(2-(1-cyclopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yloxy)propanamide;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-10-phenyl-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
1-isopropyl-5-(10-phenyl-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1H-1,2,4-triazol-3-amine;
2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-10-(pyrimidin-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
1-isopropyl-5-(10-(pyrimidin-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1H-1,2,4-triazol-3-amine;
1-(2-chlorophenyl)-5-(10-(pyrimidin-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1H-1,2,4-triazol-3-amine;
10-(4-chlorophenyl)-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
5-(10-(4-chlorophenyl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1-isopropyl-1H-1,2,4-triazol-3-amine;
10-(4-chlorophenyl)-2-(1-(2-chlorophenyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
2-(1-(2-chlorophenyl)-1H-1,2,4-triazol-5-yl)-10-phenyl-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
1-(2-chlorophenyl)-5-(10-phenyl-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1H-1,2,4-triazol-3-amine;
2-(1-(2-chlorophenyl)-1H-1,2,4-triazol-5-yl)-10-(pyrimidin-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
1-(2-chlorophenyl)-5-(10-(4-chlorophenyl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1H-1,2,4-triazol-3-amine;
9-(4-chlorophenyl)-2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
9-(4-chlorophenyl)-2-(1-(2-chlorophenyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepine;
5-(9-(4-chlorophenyl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1-isopropyl-1H-1,2,4-triazol-3-amine; and
1-(2-chlorophenyl)-5-(9-(4-chlorophenyl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-2-yl)-1H-1,2,4-triazol-3-amine.
26. A pharmaceutical composition comprised of a compound of claim 1 and a pharmaceutically acceptable carrier, glidant, diluent, or excipient.
27. The pharmaceutical composition according to claim 26, further comprising a chemotherapeutic agent, an anti-inflammatory agent, an immunomodulatory agent, a neurotropic factor, an agent for treating cardiovascular disease, an agent for treating liver disease, an anti-viral agent, an agent for treating blood disorders, an agent for treating diabetes, and an agent for treating immunodeficiency disorders.
28. A process for making a pharmaceutical composition which comprises combining a compound of claim 1 with a pharmaceutically acceptable carrier.
29. A kit for the therapeutic treatment of breast cancer, comprising:
a) a first pharmaceutical composition comprising a compound of claim 1; and
b) instructions for use in the therapeutic treatment of breast cancer.
30. The compound 1-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropan-2-ol.
31. The compound 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)ethanol.
32. The compound 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide.
33. The compound 2-(4-(2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzofimidazo1,2-d1,4oxazepin-9-yl)-1H-imidazol-1-yl)ethanol.